Task: Answer the MCQ question.
Question: Which drug has a 20.682% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1nn(C)c(C)c1CNC(=O)Nc1cccc(Cl)c1
b: COc1cc(CN2CC(=O)N(c3cc(Cl)ccc3C)C2=S)cc(OC)c1OC
Answer: b. COc1cc(CN2CC(=O)N(c3cc(Cl)ccc3C)C2=S)cc(OC)c1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(CN2CC(=O)N(c3cc(Cl)ccc3C)C2=S)cc(OC)c1OC
COc1cc(CN2CC(=O)N(c3cc(Cl)ccc3C)C2=S)cc(OC)c1OC
3-(5-chloro-2-methylphenyl)-2-sulfanylidene-1-[(3,4,5-trimethoxyphenyl)methyl]imidazolidin-4-one